Fiscal stimulus in China could help boost the world's second-largest economy to 5% GDP growth next year, SocGen analysts ...

"EPS could double to $400 by the end of the decade in our Roaring 2020s scenario," Ed Yardeni said in a recent note.

If the economy steers clear of a recession, a Fed policy error, and external shocks, there's no reason stocks won't climb ...

"On the face of this the Fed should be hiking rates with these sorts of figures, not cutting rates," Economist James ...

Medicare plans to downgrade ratings on some of the Humana's health insurance plans. The stock has fallen 23% for its worst ...

SOUTHFIELD, Mich., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Monroe® proudly announces the launch of its new Heavy Duty Chassis ...

"The continued softer trend now appears to position Tesla to potentially not grow full year unit volumes for the first time ...

Indexes fell Thursday on rising risks to oil supplies amid escalating Middle East tensions and as traders braced for Friday's ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced today that the Company will ...

The gross proceeds to the Company from the registered direct offering are estimated to be approximately $30.0 million, before deducting the placement agent’s fees and other estimated offering expenses ...

If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/ocugen-shareholder-investigation/, contact us at [email protected], or call ...